Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia

Metabotropic glutamate (mGlu) receptors are considered as candidate drug targets for the treatment of schizophrenia. These receptors form a family of eight subtypes (mGlu1 to −8), of which mGlu1 and −5 are coupled to G(q/11), and all other subtypes are coupled to G(i/o). Here, we discuss the possibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicoletti, Ferdinando, Orlando, Rosamaria, Di Menna, Luisa, Cannella, Milena, Notartomaso, Serena, Mascio, Giada, Iacovelli, Luisa, Matrisciano, Francesco, Fazio, Francesco, Caraci, Filippo, Copani, Agata, Battaglia, Giuseppe, Bruno, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413697/
https://www.ncbi.nlm.nih.gov/pubmed/30890967
http://dx.doi.org/10.3389/fpsyt.2019.00049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413697/
https://www.ncbi.nlm.nih.gov/pubmed/30890967
http://dx.doi.org/10.3389/fpsyt.2019.00049

Ejemplares similares